Newsletters
- Bay Area Newsletter
- Greater Los Angeles Newsletter
- Group Purchasing Newsletter
- Public Policy Newsletter
- Regulatory & Reimbursement Newsletter
- San Diego Newsletter
Home / Newsletters / Regulatory & Reimbursement Newsletter

Biocom California provided public comments at the FDA’s meeting on the reauthorization of PDUFA, the FDA announced a new CDER Director, and more.

The Acting Director of CDER is retiring, the FDA unveiled a new priority voucher program, conducted a CEO listening tour across the country, and launched an agency-wide artificial intelligence tool, and more.